⌘K

Home/Filings/4/0001493152-23-005464

4//SEC Filing

Cross John Harry III 4

Accession 0001493152-23-005464

CIK 0001106838other

View on SEC.gov Company Profile

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 4:45 PM ET

Size

4.8 KB

Accession

0001493152-23-005464

Insider Transaction Report

Form 4

Period: 2023-02-06

Sonnet BioTherapeutics Holdings, Inc.SONN

Cross John Harry III

Chief Financial Officer

Transactions

Tax Payment
Common Stock
2023-02-06$1.06/sh−1,960$2,078→ 23,927 total

Footnotes (1)

[F1]Includes unvested restricted stock units.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Sonnet BioTherapeutics Holdings, Inc.

CIK 0001106838

Entity typeother

Related Parties

1

filerCIK 0001806763

Filing Metadata

Form type: 4
Filed: Feb 16, 7:00 PM ET
Accepted: Feb 17, 4:45 PM ET
Size: 4.8 KB

View on SEC.gov